+44-1518-0811362022: Volume 3, Issue 2
Editorial P.1-2
A Novel Factor in Determining the Risk of Vasodilator Use in Precapillary Pulmonary Hypertension with End Stage Kidney Disease: A Single Center Experience
Author(s): Donn Sasiprapha
Opinion Article P.1-2
Impact of the Updated Definition of Oral Anticoagulants in Chronic Thromboembolic Pulmonary Hypertension
Author(s): Humbert Langleben
Mini Review P.1-2
Exhortation for Interceding with the Intent of Modifying the Outcome of Bronchoscopy during COVID-19 Outbreak
Author(s): Angela Elias
Commentary P.1-2
Influence of the Severe Acute Respiratory Syndrome Coronavirus-2 (COVID-19) Plague on Tuberculosis Services
Author(s): Alimayu Olivares
Short Communication P.1-2
General Absolute and Relative Contraindications to Lung Transplantation in Patients with Cystic Fibrosis of Donor Lungs
Author(s): Edgar Faulkner